Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 11, 2017, Pages 3461-3474

  Turan, Nefize ^a   Miller, Brandon A ^a   Heider, Robert A ^a   Nadeem, Maheen ^a   Sayeed, Iqbal ^a   Stein, Donald G ^a   Pradilla, Gustavo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; behavior (rodent); cognitive impairment; experimental; subarachnoid hemorrhage

Indexed keywords

ADHESIVE REMOVAL TEST; BEHAVIOR ASSESSMENT; ELEVATED PLUS MAZE TEST; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FUNCTIONAL INDEPENDENCE MEASURE; GLASGOW OUTCOME SCALE; INCLINED BEAM WALKING TEST; MORRIS WATER MAZE TEST; MORTALITY; NEUROLOGIC EXAMINATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RADIAL ARM MAZE TEST; RANKIN SCALE; RAT; REVIEW; ROTAROD TEST; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; ANIMAL; ANIMAL BEHAVIOR; BRAIN VASOSPASM; COGNITIVE DEFECT; COMPLICATION; DISEASE MODEL; MOUSE; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; MICE; RATS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 85032738519     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16665623     Document Type: Review

References (154)

1. Connolly ES, Jr Rabinstein AA, Carhuapoma JR, Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012; 43: 171137.
2. Shea AM, Reed SD, Curtis LH, Alexander MJ, Villani JJ, Schulman KA. Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery 2007; 61: 1131–7. discussion 7–8.
3. Labovitz DL, Halim AX, Brent B, Subarachnoid hemorrhage incidence among Whites, Blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology 2006; 26: 147–150.
4. Kirkpatrick PJ, Turner CL, Smith C, Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol 2014; 13: 666–675.
5. Macdonald RL, Higashida RT, Keller E, Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl 2013; 115: 27– a31.
6. Macdonald RL, Kassell NF, Mayer S, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008; 39: 3015–21.
7. Leijenaar JF, Dorhout Mees SM, Algra A, Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II). Int J Stroke 2015 (1 Suppl A100): 108–12.
8. Macdonald RL, Higashida RT, Keller E, Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care 2010; 13: 416–424.
9. Loch Macdonald R. Vasospasm: my first 25 years-what worked? what didn't? what next? Acta Neurochir Suppl 2015; 120: 1–10.
10. Zhang S, Wang L, Liu M, Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2010; 2: CD006778.
11. Wali B, Ishrat T, Stein DG, Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats. Behav Brain Res 2016; 305: 46–56.
12. Wali B, Sayeed I, Stein DG. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci 2011; 29: 61–71.
13. Sayeed I, Wali B, Stein DG. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007; 25: 151–159.
14. Hamm RJ. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J Neurotrauma 2001; 18: 1207–1216.
15. Scheff SW, Baldwin SA, Brown RW, Kraemer PJ. Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J Neurotrauma 1997; 14: 615–27.
16. Green EJ, Dietrich WD, van Dijk F, Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res 1992; 580: 197–204.
17. Markgraf CG, Green EJ, Hurwitz BE, Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res 1992; 575: 238–246.
18. Peterson BL, Won S, Geddes RI, Sex-related differences in effects of progesterone following neonatal hypoxic brain injury. Behav Brain Res 2015; 286: 152–165.
19. Wali B, Ishrat T, Won S, Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 2014; 137: 486–502.
20. Yousuf S, Sayeed I, Atif F, Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats. J Cereb Blood Flow Metab 2014; 34: 297–306.
21. Tang H, Hua F, Wang J, Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats. Horm Behav 2013; 64: 527–538.
22. Geddes RI, Peterson BL, Stein DG, Progesterone treatment shows benefit in female rats in a pediatric model of controlled cortical impact injury. PLoS One 2016; 11: e0146419.
23. Sozen T, Tsuchiyama R, Hasegawa Y, Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009; 40: 2519–2525.
24. Ostrowski RP, Tang J, Zhang JH. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 2006; 37: 1314–1318.
25. McGirt MJ, Lynch JR, Parra A, Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950–2956.
26. Suzuki H, Hasegawa Y, Kanamaru K, Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 2010; 41: 1783–1790.
27. Pradilla G, Garzon-Muvdi T, Ruzevick JJ, Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage. Neurosurgery 2012; 70: 747–756; discussion 56–57.
28. Cuevas P, Carceller F, Nieto I, Spasmolytic effect of acidic fibroblast growth factor in early cerebral vasospasm in the rat. Surg Neurol 1998; 49: 176–179; discussion 9–80.
29. Jang YG, Ilodigwe D, Macdonald RL. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009; 10: 141–147.
30. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1–21.
31. Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 2014; 10: 44–58.
32. Miller BA, Turan N, Chau M, Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int 2014; 2014: 384342.
33. Chaichana KL, Pradilla G, Huang J, Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg 2010; 73: 22–41.
34. Bell JD, Thomas TC, Lass E, Platelet-mediated changes to neuronal glutamate receptor expression at sites of microthrombosis following experimental subarachnoid hemorrhage. J Neurosurg 2014, pp. 6: 1424–1431.
35. Gouveia K, Hurst JL. Reducing mouse anxiety during handling: effect of experience with handling tunnels. PLoS One 2013; 8: e66401.
36. Yeo SS, Choi BY, Chang CH, Evidence of corticospinal tract injury at midbrain in patients with subarachnoid hemorrhage. Stroke 2012; 43: 223–941.
37. Wallmark S, Lundstrom E, Wikstrom J, Ronne-Engstrom E. Attention deficits after aneurysmal subarachnoid hemorrhage measured using the test of variables of attention. Stroke 2015; 46: 1374–1376.
38. Ellmore TM, Rohlffs F, Khursheed F. FMRI of working memory impairment after recovery from subarachnoid hemorrhage. Front Neurol 2013; 4: 179.
39. Bendel P, Koivisto T, Niskanen E, Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study. Neuroradiology 2009; 51: 711–722.
40. Bendel P, Koivisto T, Aikia M, Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome. AJNR Am J Neuroradiol 2010; 31: 370–376.
41. Bendel P, Koivisto T, Hanninen T, Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology 2006; 67: 575–582.
42. Sugawara T, Ayer R, Jadhav V, A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008; 167: 327–334.
43. Shishido H, Egashira Y, Okubo S, A magnetic resonance imaging grading system for subarachnoid hemorrhage severity in a rat model. J Neurosci Meth 2015; 243: 115–119.
44. Hurst JL, West RS. Taming anxiety in laboratory mice. Nat Meth 2010; 7: 825–856.
45. Deacon RM. Housing, husbandry and handling of rodents for behavioral experiments. Nat Protoc 2006; 1: 936–946.
46. Garcia JH, Wagner S, Liu KF, Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26: 627–634. discussion 35.
47. Suzuki H and Zhang JH. Neurobehavioral assessments of subarachnoid hemorrhage. In: Chen J, Xu X-M, Xu CZ, et al. (eds) Animal Models of Acute Neurological Injuries II: Injury and Mechanistic Assessments. vol 1. Totowa, NJ: Humana Press, 2012, pp. 435–440
48. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1957; 46: 208–209.
49. Mesis RG, Wang H, Lombard FW, Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 2006; 21: E4.
50. Thal SC, Mebmer K, Schmid-Elsaesser R, Neurological impairment in rats after subarachnoid hemorrhage – a comparison of functional tests. J Neurol Sci 2008; 268: 150–159.
51. Takata K, Sheng H, Borel CO, Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol 2009; 21: 326–333.
52. Sheng H, Reynolds JD, Auten RL, Pharmacologically augmented S-nitrosylated hemoglobin improves recovery from murine subarachnoid hemorrhage. Stroke 2011; 42: 471–476.
53. Sherchan P, Lekic T, Suzuki H, Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats. J Neurotrauma 2011; 28: 2503–2512.
54. Hu Q, Vakhmjanin A, Li B, Tang J, Zhang JH. Hyperbaric oxygen therapy fails to reduce hydrocephalus formation following subarachnoid hemorrhage in rats. Med Gas Res 2014; 4: 12.
55. Wang H, James ML, Venkatraman TN, pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH. Neurocrit Care 2014; 20: 119–131.
56. Siler DA, Berlow YA, Kukino A, Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage. Stroke 2015; 7: 1916–1922.
57. Sasaki T, Hoffmann U, Kobayashi M, et al. Neurocrit Care. Epub ahead of print 19 February 2016. DOI: 10.1007/s12028-016-0250-1
58. Mutoh T, Sasaki K, Yamamoto Y, Isoflurane postconditioning with cardiac support promotes recovery from early brain injury in mice after severe subarachnoid hemorrhage. Life Sci 2016; 153: 35–40.
59. Wu Y, Pang J, Peng J, An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage. Neurosci Lett 2016; 627: 92–99.
60. Siler DA, Berlow YA, Kukino A, Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage. Stroke 2015; 46: 1916–1922.
61. Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994; 61: 59–64.
62. Hollig A, Weinandy A, Liu J, beneficial properties of argon after experimental subarachnoid hemorrhage: early treatment reduces mortality and influences hippocampal protein expression. Crit Care Med 2016; 44: e520–e529.
63. Boyko M, Azab AN, Kuts R, The neuro-behavioral profile in rats after subarachnoid hemorrhage. Brain Res 2013; 1491: 109–116.
64. Germano AF, Dixon CE, d'Avella D, Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 1994; 11: 345–353.
65. Combs DJ, D'Alecy LG. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. Stroke 1987; 18: 503–511.
66. Modianos DT, Pfaff DW. Brain stem and cerebellar lesions in female rats. I. Tests of posture and movement. Brain Res 1976; 106: 31–46.
67. Germano A, Imperatore C, d'Avella D, Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurgery 1998; 88: 1075–1081.
68. Merlo L, Cimino F, Scibilia A, Simvastatin administration ameliorates neurobehavioral consequences of subarachnoid hemorrhage in the rat. J Neurotrauma 2011; 28: 2493–2501.
69. Germano A, Caffo M, Angileri FF, NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma 2007; 24: 732–744.
70. Silasi G, Colbourne F. Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 2009; 198: 380–387.
71. Meyer OA, Tilson HA, Byrd WC, A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1979; 1: 233–236.
72. Ari C, Poff AM, Held HE, Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS One 2014; 9: e103526.
73. Ferrara A, El Bejaoui S, Seyen S, Tirelli E, Plumier JC. The usefulness of operant conditioning procedures to assess long-lasting deficits following transient focal ischemia in mice. Behav Brain Res 2009; 205: 525–534.
74. Tsai YD, Liliang PC, Cho CL, Delayed neurovascular inflammation after mild traumatic brain injury in rats. Brain Inj 2013; 27: 361–365.
75. Deacon RM. Measuring motor coordination in mice. J Visual Exp 2013; 75: e2609.
76. Vrinten DH, Hamers FF. ‘CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain 2003; 102: 203–209.
77. Deumens R, Marinangeli C, Bozkurt A, Brook GA. Assessing motor outcome and functional recovery following nerve injury. Meth Mol Biol 2014; 1162: 179–188.
78. Van Meeteren NL, Eggers R, Lankhorst AJ, Locomotor recovery after spinal cord contusion injury in rats is improved by spontaneous exercise. J Neurotrauma 2003; 20: 1029–1037.
79. Bozkurt A, Deumens R, Scheffel J, CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury. J Neurosci Meth 2008; 173: 91–98.
80. Vlamings R, Visser-Vandewalle V, Koopmans G, High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats. Neuroscience 2007; 148: 815–823.
81. Zhou M, Zhang W, Chang J, Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease. Neurosci Lett 2014; 584C: 184–189.
82. Encarnacion A, Horie N, Keren-Gill H, Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Meth 2011; 196: 247–257.
83. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 1984; 11: 47–60.
84. Rapp PR, Rosenberg RA, Gallagher M. An evaluation of spatial information processing in aged rats. Behav Neurosci 1987; 101: 3–12.
85. Morris RG, Schenk F, Tweedie F, Ibotenate lesions of hippocampus and/or subiculum: dissociating components of allocentric spatial learning. Eur J Neurosci 1990; 2: 1016–1028.
86. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1: 848–858.
87. Kooijman E, Nijboer CH, van Velthoven CT, Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat. PLoS One 2014; 9: e90584.
88. Silasi G, Colbourne F. Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 2009; 198: 380–387.
89. Milner E, Holtzman JC, Friess S, Endovascular perforation subarachnoid hemorrhage fails to cause Morris water maze deficits in the mouse. J Cereb Blood Flow Metab 2014; 34: 1571–1572.
90. Atangana EN, Homburg D, Vajkoczy P, Mouse cerebral magnetic resonance imaging fails to visualize brain volume changes after experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 2015; 157: 37–42.
91. Liu Y, Qiu J, Wang Z, Dimethylfumarate alleviates early brain injury and secondary cognitive deficits after experimental subarachnoid hemorrhage via activation of Keap1-Nrf2-ARE system. J Neurosurg 2015; 123: 915–923.
92. Feng D, Wang W, Dong Y, Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-kappaB signaling pathway. Neuroscience 2014; 268: 21–32.
93. Takata K, Sheng H, Borel CO, Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol 2008; 213: 336–344.
94. Takata K, Sheng H, Borel CO, Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesth 2009; 21: 326–333.
95. Jeon H, Ai J, Sabri M, Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience 2010; 169: 1805–1814.
96. Chen G, Li Q, Feng D, Expression of NR2B in different brain regions and effect of NR2B antagonism on learning deficits after experimental subarachnoid hemorrhage. Neuroscience 2013; 231: 136–144.
97. Sun X, Ji C, Hu T, Wang Z, Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. J Neuroinflammation 2013; 10: 157.
98. Wang Z, Ji C, Wu L, Tert-butylhydroquinone alleviates early brain injury and cognitive dysfunction after experimental subarachnoid hemorrhage: role of Keap1/Nrf2/ARE pathway. PLoS One 2014; 9: e97685.
99. Dong Y, Li Y, Feng D, Protective effect of HIF-1alpha against hippocampal apoptosis and cognitive dysfunction in an experimental rat model of subarachnoid hemorrhage. Brain Res 2013; 1517: 114–121.
100. Viana MB, Tomaz C, Graeff FG. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 1994; 49: 549–554.
101. Korte SM, De Boer SF. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 2003; 463: 163–175.
102. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985; 14: 149–167.
103. Graeff FG, Netto CF, Zangrossi H, Jr. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 1998; 23: 237–246.
104. Zangrossi H, Jr Graeff FG. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 1997; 44: 1–5.
105. Lackner P, Vahmjanin A, Hu Q, Chronic hydrocephalus after experimental subarachnoid hemorrhage. PloS One 2013; 8: e69571.
106. Schallert T, Upchurch M, Lobaugh N, Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 1982; 16: 455–462.
107. Chen SF, Hung TH, Chen CC, Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life sciences 2007; 81: 288–98.
108. Esneault E, Pacary E, Eddi D, Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2008; 28: 1552–1563.
109. Bouet V, Boulouard M, Toutain J, The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc 2009; 4: 1560–1564.
110. Macdonald RL, Jaja B, Cusimano MD, SAHIT Investigators – on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res 2013; 4: 286–296.
111. Stein DG. Embracing failure: WHAT the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj 2015; 29: 1259–1272.
112. Howard RB, Sayeed I, Stein D. Suboptimal dosing parameters as possible factors in the negative Phase III clinical trials of progesterone in TBI. J Neurotrauma. Epub ahead of print 15 September 2015. DOI: 10.1089/neu.2015.4179.
113. Poon W, Vos P, Muresanu D, Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods. J Neurotrauma 2015; 32: 571–580.
114. Maas AI, Menon DK, Lingsma HF, Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. J Neurotrauma 2012; 29: 32–46.
115. Wikstrom J, Georgoulas G, Moutsopoulos T, Seferiadis A. Intelligent data analysis of instrumented gait data in stroke patients-a systematic review. Comput Biol Med 2014; 51: 61–72.
116. Olton DS and Samuelson RJ. Remembrance of places passed: Spatial memory in rats. J Exp Psychol Anim B 1976; 2: 97–116
117. Bae JH, Kang SH, Seo KM, Relationship between grip and pinch strength and activities of daily living in stroke patients. Ann Rehabil Med 2015; 39: 752–762.
118. Ahlander AC, Persson M, Emanuelson I. Fifteen-year follow-up of upper limb function in children with moderate to severe traumatic brain injury. J Rehabil Med 2013; 45: 815–819.
119. Turan N, Heider RA, Zaharieva D, Sex differences in the formation of intracranial aneurysms and incidence and outcome of subarachnoid hemorrhage: review of experimental and human studies. Transl Stroke Res 2016; 7: 12–19.
120. Friedrich V, Bederson JB, Sehba FA. Gender influences the initial impact of subarachnoid hemorrhage: an experimental investigation. PLoS One 2013; 8: e80101.
121. Friedrich V, Bi W, Sehba FA. Sexual dimorphism in gene expression after aneurysmal subarachnoid hemorrhage. Neurol Res 2015; 37: 1054–1059.
122. Macdonald RL, Higashida RT, Keller E, Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 2012; 43: 1463–1469.
123. Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10: 618–625.
124. Young AM, Karri SK, Helmy A, Pharmacologic Management of Subarachnoid Hemorrhage. World Neurosurg 2015; 84: 28–35.
125. Parra A, McGirt MJ, Sheng H, Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res 2002; 24: 510–516.
126. McGirt MJ, Parra A, Sheng H, Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002; 33: 2317–23.
127. Feiler S, Friedrich B, Scholler K, Thal SC, Plesnila N. Standardized induction of subarachnoid hemorrhage in mice by intracranial pressure monitoring. J Neurosci Meth 2010; 190: 164–170.
128. Tait MJ, Saadoun S, Bell BA, Verkman AS, Papadopoulos MC. Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage. Neuroscience 2010; 167: 60–67.
129. Han BH, Vellimana AK, Zhou ML, Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage. Neurosurgery 2012; 70: 178–86. discussion 86–87.
130. Terpolilli NA, Feiler S, Dienel A, Nitric oxide inhalation reduces brain damage, prevents mortality, and improves neurological outcome after subarachnoid hemorrhage by resolving early pial microvasospasms. J Cereb Blood Flow Metab. Epub ahead of print 2 November 2015. DOI: 10.1177/0271678X15605848.
131. Egashira Y, Shishido H, Hua Y, Keep RF, Xi G. New grading system based on magnetic resonance imaging in a mouse model of subarachnoid hemorrhage. Stroke 2015; 46: 582–584.
132. Mutoh T, Sasaki K, Nakamura K, Value of three-dimensional maximum intensity projection display to assist in magnetic resonance imaging (MRI)-based grading in a mouse model of subarachnoid hemorrhage. Med Sci Monit 2016; 22: 2050–2055.
133. Fujimoto M, Shiba M, Kawakita F, Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. J Neurosurg 2016; 124: 1693–1702.
134. Vatter H, Weidauer S, Konczalla J, Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 2006; 58: 1190–1197. discussion 1190–1197.
135. Yatsushige H, Calvert JW, Cahill J, Limited role of inducible nitric oxide synthase in blood-brain barrier function after experimental subarachnoid hemorrhage. J Neurotrauma 2006; 23: 1874–1882.
136. Thal SC, Sporer S, Klopotowski M, Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg 2009; 111: 988–994.
137. Ayer R, Chen W, Sugawara T, Role of gap junctions in early brain injury following subarachnoid hemorrhage. Brain Res 2010; 1315: 150–158.
138. Duris K, Manaenko A, Suzuki H, alpha7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats. Stroke 2011; 42: 3530–3536.
139. Wu CT, Wen LL, Wong CS, Temporal changes in glutamate, glutamate transporters, basilar arteries wall thickness, and neuronal variability in an experimental rat model of subarachnoid hemorrhage. Anesth Analg 2011; 112: 666–673.
140. Khalili MA, Anvari M, Hekmati-Moghadam SH, Therapeutic benefit of intravenous transplantation of mesenchymal stem cells after experimental subarachnoid hemorrhage in rats. J Stroke Cerebrovasc Dis 2012; 21: 445–451.
141. Fujii M, Duris K, Altay O, Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats. Neurochem Int 2012; 60: 327–333.
142. Hockel K, Scholler K, Trabold R, Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke 2012; 43: 227–232.
143. Chen S, Ma Q, Krafft PR, P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis 2013; 58: 296–307.
144. Hong Y, Shao A, Wang J, Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3beta signaling pathway. PLoS One 2014; 9: e96212.
145. Zhao D, Liu Q, Ji Y, Effect of 18beta-glycyrrhetinic acid on cerebral vasospasm caused by asymmetric dimethylarginine after experimental subarachnoid hemorrhage in rats. Neurol Res 2015; 37: 476–483.
146. Chen Y, Luo C, Zhao M, Administration of a PTEN inhibitor BPV(pic) attenuates early brain injury via modulating AMPA receptor subunits after subarachnoid hemorrhage in rats. Neurosci Lett 2015; 588: 131–136.
147. He Y, Xu L, Li B, Macrophage-inducible c-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats. Stroke 2015; 46: 2277–2286.
148. He J, Liu M, Liu Z, Recombinant osteopontin attenuates experimental cerebral vasospasm following subarachnoid hemorrhage in rats through an anti-apoptotic mechanism. Brain Res 2015; 1611: 74–83.
149. Zuo S, Li W, Li Q, Protective effects of Ephedra sinica extract on blood-brain barrier integrity and neurological function correlate with complement C3 reduction after subarachnoid hemorrhage in rats. Neurosci Lett 2015; 609: 216–222.
150. Zhou C, Xie G, Wang C, Decreased progranulin levels in patients and rats with subarachnoid hemorrhage: a potential role in inhibiting inflammation by suppressing neutrophil recruitment. J Neuroinflammation 2015; 12: 200.
151. Zhang T, Su J, Guo B, Apigenin protects blood-brain barrier and ameliorates early brain injury by inhibiting TLR4-mediated inflammatory pathway in subarachnoid hemorrhage rats. Int Immunopharmacol 2015; 28: 79–87.
152. Tian Y, Guo SX, Li JR, Topiramate attenuates early brain injury following subarachnoid haemorrhage in rats via duplex protection against inflammation and neuronal cell death. Brain Res 2015; 1622: 174–185.
153. Teng Z, Jiang L, Hu Q, Peroxisome proliferator-activated receptor beta/delta alleviates early brain injury after subarachnoid hemorrhage in rats. Stroke 2016; 47: 196–205.
154. Yin C, Huang GF, Sun XC, Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats. Neuropharmacology 2016; 108: 316–323.